In the last trading session, 14.9 million shares of the Sarepta Therapeutics Inc (NASDAQ:SRPT) were traded, and its beta was 0.77. Most recently the company’s share price was $46.75, and it changed around -$16.91 or -26.56% from the last close, which brings the market valuation of the company to $4.59B. SRPT currently trades at a discount to its 52-week high of $173.25, offering almost -270.59% off that amount. The share price’s 52-week low was $48.01, which indicates that the current value has fallen by an impressive -2.7% since then.
Sarepta Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 25 analysts rate the stock as a Sell; another 7 rate it as Overweight. Among the rest, 4 recommended SRPT as a Hold, whereas 14 deemed it a Buy, and 0 rated it as Underweight.
Sarepta Therapeutics Inc (NASDAQ:SRPT) trade information
Instantly SRPT has showed a red trend with a performance of -26.56% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 64.80 on recent trading dayincreased the stock’s daily price by 27.85%. The company’s shares are currently down -61.55% year-to-date, but still down -23.17% over the last five days. On the other hand, Sarepta Therapeutics Inc (NASDAQ:SRPT) is -14.11% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $180, which translates to bulls needing to increase their stock price by 74.03% from its current value. Analyst projections state that SRPT is forecast to be at a low of $110 and a high of $202.
Sarepta Therapeutics Inc earnings are expected to increase by 70.20% in 2025, but the outlook is positive 92.16% per year for the next five years.
SRPT Dividends
Sarepta Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
VANGUARD GROUP INC, with 9.5496% or 9.04 million shares worth $1.43 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
GROWTH FUND OF AMERICA and iShares Trust-iShares Core S&P Mid-Cap ETF were the top two Mutual Funds as of Mar 31, 2025 . The former held 3.15 shares worth $147.26 million, making up 3.21% of all outstanding shares. On the other hand, iShares Trust-iShares Core S&P Mid-Cap ETF held roughly 3.12 shares worth around $145.86 million, which represents about 3.18% of the total shares outstanding.
